title: beta-Ray treatment of malignant epibulbar melanoma.
abstract: Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003228:Conjunctiva; D005134:Eye Neoplasms / Q000209:etiology / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000209:etiology / Q000532:radiotherapy* / Q000601:surgery; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000150:complications; D011230:Precancerous Conditions; D011879:Radiotherapy Dosage; D013326:Strontium Radioisotopes / Q000627:therapeutic use*
chemical_list: D013326:Strontium Radioisotopes